MEXC Lists Ondo Tokenized Stock Moderna (MRNAON), Expanding Access to U.S. Biotech Exposure

MEXC has expanded its tokenized stock offerings by listing the MRNAON/USDT trading pair, providing users with exposure to Moderna, Inc. shares. This listing follows a significant 177% rally in Moderna's stock price, which was triggered by positive clinical trial results for its investigational personalized mRNA cancer vaccine. The MRNAON token, facilitated through a collaboration with Ondo, allows investors outside the United States to access traditional public securities on-chain. By integrating these assets into its spot market, MEXC aims to capitalize on the growing demand for tokenized equities, which accounted for 62% of the exchange's TradFi spot trading volume in July. The move highlights the increasing utility of tokenized stocks as freely transferable assets within the DeFi ecosystem. MEXC is further incentivizing this activity through its 'Stock Season' event, which offers zero-fee trading and a $500,000 prize pool. This development underscores the broader trend of bridging traditional financial markets with blockchain infrastructure to enhance global accessibility.